Minimal change disease differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 24: | Line 24: | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Kidney diseases]] | [[Category:Kidney diseases]] | ||
[[Category:Urology]] | [[Category:Urology]] |
Revision as of 15:58, 5 April 2015
Minimal Change Disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Minimal change disease differential diagnosis On the Web |
American Roentgen Ray Society Images of Minimal change disease differential diagnosis |
Risk calculators and risk factors for Minimal change disease differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, Serge Korjian
Overview
The differential diagnosis of minimal change disease must always include other renal etiologies of nephrotic syndrome, such as focal segmental glomerulosclerosis (FSGS) and IgM nephropathy, and causes of peripheral edema and hypoalbuminemia, such as congestive heart failure, liver cirrhosis, and protein-losing enteropathy.
Differential Diagnosis
- Focal segmental glomerulosclerosis (FSGS)
- IgM nephropathy
- C1q nephropathy
- IgG nephropathy
- C3 mesangial nephropathy
- Membranoproliferative glomerulonephritis
- Congestive heart failure
- Liver cirrhosis
- Protein-losing enteropathy
- Kwashiorkor